
Rebecca E. Prouty
Examiner (ID: 3961, Phone: (571)272-0937 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652, 1814 |
| Total Applications | 1570 |
| Issued Applications | 849 |
| Pending Applications | 157 |
| Abandoned Applications | 568 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5687772
[patent_doc_number] => 20060286087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof'
[patent_app_type] => utility
[patent_app_number] => 11/429422
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11093
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429422
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429422 | Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof | May 4, 2006 | Abandoned |
Array
(
[id] => 5204947
[patent_doc_number] => 20070026428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Combinatorial expression of split caspase molecules'
[patent_app_type] => utility
[patent_app_number] => 11/416845
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13325
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20070026428.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416845 | Combinatorial expression of split caspase molecules | May 1, 2006 | Abandoned |
Array
(
[id] => 4608632
[patent_doc_number] => 07993887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-09
[patent_title] => 'Microorganism, lipid-modifying agent, and the method of manufacturing 2-acyl lysophospholipids'
[patent_app_type] => utility
[patent_app_number] => 11/920856
[patent_app_country] => US
[patent_app_date] => 2006-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2687
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/993/07993887.pdf
[firstpage_image] =>[orig_patent_app_number] => 11920856
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/920856 | Microorganism, lipid-modifying agent, and the method of manufacturing 2-acyl lysophospholipids | Apr 10, 2006 | Issued |
Array
(
[id] => 5784298
[patent_doc_number] => 20060204489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Protein C derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/397046
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8766
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204489.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397046
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397046 | Protein C derivatives | Apr 2, 2006 | Abandoned |
Array
(
[id] => 5662324
[patent_doc_number] => 20060252920
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Sequence-determined DNA fragments encoding cyclopropyl isomerase proteins'
[patent_app_type] => utility
[patent_app_number] => 11/387751
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16498
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252920.pdf
[firstpage_image] =>[orig_patent_app_number] => 11387751
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/387751 | Sequence-determined DNA fragments encoding cyclopropyl isomerase proteins | Mar 22, 2006 | Abandoned |
| 11/377940 | Tissue type plasminogen activator (t-PA) variants: composition and methods of use | Mar 14, 2006 | Abandoned |
Array
(
[id] => 4595392
[patent_doc_number] => 07981602
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Photoproteins with enhanced bioluminescence and assays using the same'
[patent_app_type] => utility
[patent_app_number] => 10/587523
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 6726
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981602.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587523
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587523 | Photoproteins with enhanced bioluminescence and assays using the same | Mar 8, 2006 | Issued |
Array
(
[id] => 102300
[patent_doc_number] => 07723097
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Escherichia coli strains that over-produce L-threonine and processes for their production'
[patent_app_type] => utility
[patent_app_number] => 11/371732
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15196
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371732
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371732 | Escherichia coli strains that over-produce L-threonine and processes for their production | Mar 8, 2006 | Issued |
Array
(
[id] => 121232
[patent_doc_number] => 07709234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'α-1,3-fucosyltransferase'
[patent_app_type] => utility
[patent_app_number] => 11/276029
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 31019
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11276029
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/276029 | α-1,3-fucosyltransferase | Feb 9, 2006 | Issued |
Array
(
[id] => 4599175
[patent_doc_number] => 07977082
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'Isomaltulose synthases, polynucleotides encoding them and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/345362
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 41355
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/977/07977082.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345362 | Isomaltulose synthases, polynucleotides encoding them and uses therefor | Feb 1, 2006 | Issued |
Array
(
[id] => 314684
[patent_doc_number] => 07524654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Isomaltulose synthases, polynucleotides encoding them and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/345363
[patent_app_country] => US
[patent_app_date] => 2006-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 41283
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524654.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345363
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345363 | Isomaltulose synthases, polynucleotides encoding them and uses therefor | Feb 1, 2006 | Issued |
Array
(
[id] => 122458
[patent_doc_number] => 07704724
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-04-27
[patent_title] => 'Catalytic buffering systems'
[patent_app_type] => utility
[patent_app_number] => 11/345679
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 4
[patent_no_of_words] => 8231
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/704/07704724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11345679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/345679 | Catalytic buffering systems | Jan 25, 2006 | Issued |
Array
(
[id] => 5677858
[patent_doc_number] => 20060183214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Modulation of plasma membrane Human Leukocyte Elastase'
[patent_app_type] => utility
[patent_app_number] => 11/334697
[patent_app_country] => US
[patent_app_date] => 2006-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1779
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183214.pdf
[firstpage_image] =>[orig_patent_app_number] => 11334697
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/334697 | Modulation of plasma membrane Human Leukocyte Elastase | Jan 17, 2006 | Abandoned |
Array
(
[id] => 4990998
[patent_doc_number] => 20070157339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Biochemical route to astaxanthin'
[patent_app_type] => utility
[patent_app_number] => 11/324236
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7127
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20070157339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324236
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324236 | Biochemical route to astaxanthin | Jan 3, 2006 | Abandoned |
Array
(
[id] => 5776687
[patent_doc_number] => 20060105327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma'
[patent_app_type] => utility
[patent_app_number] => 11/322863
[patent_app_country] => US
[patent_app_date] => 2005-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 20871
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20060105327.pdf
[firstpage_image] =>[orig_patent_app_number] => 11322863
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/322863 | Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma | Dec 28, 2005 | Abandoned |
Array
(
[id] => 5678359
[patent_doc_number] => 20060183715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Sulfated fucoglucuronomannan'
[patent_app_type] => utility
[patent_app_number] => 11/318452
[patent_app_country] => US
[patent_app_date] => 2005-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11006
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183715.pdf
[firstpage_image] =>[orig_patent_app_number] => 11318452
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/318452 | Sulfated fucoglucuronomannan | Dec 27, 2005 | Abandoned |
Array
(
[id] => 5454858
[patent_doc_number] => 20090070895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-12
[patent_title] => 'VACUOLE TARGETING PEPTIDE AND NUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 11/722654
[patent_app_country] => US
[patent_app_date] => 2005-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 16638
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20090070895.pdf
[firstpage_image] =>[orig_patent_app_number] => 11722654
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/722654 | VACUOLE TARGETING PEPTIDE AND NUCLEIC ACID | Dec 22, 2005 | Abandoned |
Array
(
[id] => 5912926
[patent_doc_number] => 20060127988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Synthetic nucleic acid molecule compositions and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/316042
[patent_app_country] => US
[patent_app_date] => 2005-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 25587
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127988.pdf
[firstpage_image] =>[orig_patent_app_number] => 11316042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/316042 | Synthetic nucleic acid molecule compositions and methods of preparation | Dec 21, 2005 | Abandoned |
Array
(
[id] => 5694190
[patent_doc_number] => 20060154337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Gene encoding chondroitinase ABC and uses therefor'
[patent_app_type] => utility
[patent_app_number] => 11/313169
[patent_app_country] => US
[patent_app_date] => 2005-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8102
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11313169
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/313169 | Gene encoding chondroitinase ABC and uses therefor | Dec 19, 2005 | Abandoned |
Array
(
[id] => 5596200
[patent_doc_number] => 20060160117
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Polynucleotide motor, a motor system, their preparation and uses'
[patent_app_type] => utility
[patent_app_number] => 11/303023
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9838
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160117.pdf
[firstpage_image] =>[orig_patent_app_number] => 11303023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/303023 | Polynucleotide motor, a motor system, their preparation and uses | Dec 15, 2005 | Abandoned |